| Bioactivity | Anticancer agent 55 is a potent anticancer agent. Anticancer agent 55 shows anticancer activity via reducing the cell viability and cell migration in a dose-dependent manner. Anticancer agent 55 induces apoptosis. Anticancer agent 55 has the potential for the research of prostate cancer and breast cancer[1]. |
| Invitro | Anticancer agent 55 (compound 3h) (0-100 µM; 48 h) inhibits cell viability with IC50s of 1.18 µM and 1.95 µM for PC-3, MCF-7 cells, respectively[1].Anticancer agent 55 (0, 1, 3, 10 µM; 24 h) inhibits cell migration of PC-3 cells and MCF-7 cells in a dose-dependent manner[1].Anticancer agent 55 (0, 1, 3, 10 µM; 12, 24 h) induces apoptosis by increases the caspase-3 activity and cleaved PARP levels[1]. Cell Viability Assay[1] Cell Line: |
| Name | Anticancer agent 55 |
| CAS | 2408800-91-7 |
| Formula | C28H21Br2FN2O2 |
| Molar Mass | 596.28 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |